Understanding Cytochrome P450 Enzyme Substrate Inhibition and Prospects for Elimination Strategies
Yisang Zhang,Guobin Zhang,Taichang Wang,Yu Chen,Junqing Wang,Piwu Li,Ruiming Wang,Jing Su
DOI: https://doi.org/10.1002/cbic.202400297
IF: 3.2
2024-09-19
ChemBioChem
Abstract:Substrate inhibition, a form of atypical Michaelis‐Menten kinetics, results in reduced enzyme activity due to excessive substrate binding to CYP450, adversely affecting product formation. This occurs because CYP450 possesses multiple active sites. Further details will be explored in the main text. Overcoming this requires methods like enzyme immobilization, batch feeding, biphasic systems, and protein engineering. Cytochrome P450 (CYP450) enzymes, which are widely distributed and pivotal in various biochemical reactions, catalyze diverse processes such as hydroxylation, epoxidation, dehydrogenation, dealkylation, nitrification, and bond formation. These enzymes have been applied in drug metabolism, antibiotic production, bioremediation, and fine chemical synthesis. Recent research revealed that CYP450 catalytic kinetics deviated from the classic Michaelis–Menten model. A notable substrate inhibition phenomenon that affects the catalytic efficiency of CYP450 at high substrate concentrations was identified. However, the substrate inhibition of various reactions catalyzed by CYP450 enzymes have not been comprehensively reviewed. This review describes CYP450 substrate inhibition examples and atypical Michaelis–Menten kinetic models, and provides insight into mechanisms of these enzymes. We also reviewed 3D structure and dynamics of CYP450 with substrate binding. Outline methods for alleviating substrate inhibition in CYP450 and other enzymes, including traditional fermentation approaches and protein engineering modifications. The comprehensive analysis presented in this study lays the foundation for enhancing the catalytic efficiency of CYP450 by deregulating substrate inhibition.
biochemistry & molecular biology,chemistry, medicinal